{"id":"https://openalex.org/W2979558564","doi":"https://doi.org/10.1530/eje-19-0566","title":"MANAGEMENT OF ENDOCRINE DISEASE: Are all GLP-1 agonists equal in the treatment of type 2 diabetes?","display_name":"MANAGEMENT OF ENDOCRINE DISEASE: Are all GLP-1 agonists equal in the treatment of type 2 diabetes?","alternate_titles":[],"publication_year":2019,"publication_date":"2019-10-10","ids":{"openalex":"https://openalex.org/W2979558564","doi":"https://doi.org/10.1530/eje-19-0566","mag":"2979558564","pmid":"https://pubmed.ncbi.nlm.nih.gov/31600725"},"language":"en","primary_location":{"id":"doi:10.1530/eje-19-0566","doi":"https://doi.org/10.1530/eje-19-0566","is_oa":false,"landing_page_url":"https://doi.org/10.1530/eje-19-0566","pdf_url":null,"source":{"id":"https://openalex.org/S4210218062","display_name":"European Journal of Endocrinology","issn_l":"0804-4643","issn":["0804-4643","1479-683X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Journal of Endocrinology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2979558564"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5067359287","display_name":"Michael Albrecht Nauck","orcid":"https://orcid.org/0000-0002-5749-6954","observed_orcids":["https://orcid.org/0000-0002-5749-6954","https://orcid.org/0000-0003-2455-0472"]},"institutions":[{"id":"https://openalex.org/I4210138993","display_name":"St. Josef-Hospital","ror":"https://ror.org/046vare28","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I2799784675","https://openalex.org/I4210138993","https://openalex.org/I4210153564"]},{"id":"https://openalex.org/I904495901","display_name":"Ruhr University Bochum","ror":"https://ror.org/04tsk2644","country_code":"DE","type":"education","lineage":["https://openalex.org/I904495901"]}],"countries":["DE"],"is_corresponding":true,"raw_author_name":"Michael A Nauck","raw_affiliation_strings":["1Diabetes Division, St. Josef-Hospital, Ruhr-University of Bochum, Bochum, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Diabetes Division, St. Josef-Hospital, Ruhr-University of Bochum, Bochum, Germany","institution_ids":["https://openalex.org/I4210138993","https://openalex.org/I904495901"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5002832666","display_name":"Juris Jendrik Meier","orcid":"https://orcid.org/0000-0002-5835-8019","observed_orcids":["https://orcid.org/0000-0002-5835-8019"]},"institutions":[{"id":"https://openalex.org/I4210138993","display_name":"St. Josef-Hospital","ror":"https://ror.org/046vare28","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I2799784675","https://openalex.org/I4210138993","https://openalex.org/I4210153564"]},{"id":"https://openalex.org/I904495901","display_name":"Ruhr University Bochum","ror":"https://ror.org/04tsk2644","country_code":"DE","type":"education","lineage":["https://openalex.org/I904495901"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Juris J Meier","raw_affiliation_strings":["1Diabetes Division, St. Josef-Hospital, Ruhr-University of Bochum, Bochum, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Diabetes Division, St. Josef-Hospital, Ruhr-University of Bochum, Bochum, Germany","institution_ids":["https://openalex.org/I4210138993","https://openalex.org/I904495901"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5067359287"],"corresponding_institution_ids":["https://openalex.org/I4210138993","https://openalex.org/I904495901"],"apc_list":{"value":3798,"currency":"EUR","value_usd":4292},"apc_paid":null,"fwci":16.2073,"has_fulltext":false,"cited_by_count":294,"citation_normalized_percentile":{"value":0.99708648,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":99,"max":100},"biblio":{"volume":"181","issue":"6","first_page":"R211","last_page":"R234"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10198","display_name":"Heart Failure Treatment and Management","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/glp-1-receptor-agonists","display_name":"GLP-1 receptor agonists","score":0.996999979019165},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9909999966621399},{"id":"https://openalex.org/keywords/exenatide","display_name":"exenatide","score":0.9120000004768372},{"id":"https://openalex.org/keywords/liraglutide","display_name":"liraglutide","score":0.972000002861023},{"id":"https://openalex.org/keywords/semaglutide","display_name":"semaglutide","score":0.9369999766349792},{"id":"https://openalex.org/keywords/dulaglutide","display_name":"dulaglutide","score":0.8920000195503235},{"id":"https://openalex.org/keywords/albiglutide","display_name":"albiglutide","score":0.9229999780654907},{"id":"https://openalex.org/keywords/lixisenatide","display_name":"lixisenatide","score":0.9909999966621399},{"id":"https://openalex.org/keywords/oral-semaglutide","display_name":"oral semaglutide","score":0.8809999823570251},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.7950000166893005},{"id":"https://openalex.org/keywords/glycemic-control","display_name":"glycemic control","score":0.7580000162124634},{"id":"https://openalex.org/keywords/weight-loss","display_name":"weight loss","score":0.8109999895095825},{"id":"https://openalex.org/keywords/cardiovascular-outcomes","display_name":"cardiovascular outcomes","score":0.8870000243186951},{"id":"https://openalex.org/keywords/major-adverse-cardiovascular-events","display_name":"major adverse cardiovascular events","score":0.9430000185966492},{"id":"https://openalex.org/keywords/cardiovascular-mortality","display_name":"cardiovascular mortality","score":0.6899999976158142},{"id":"https://openalex.org/keywords/heart-failure","display_name":"heart failure","score":0.7269999980926514},{"id":"https://openalex.org/keywords/pre-existing-cardiovascular-disease","display_name":"pre-existing cardiovascular disease","score":0.7639999985694885}],"concepts":[{"id":"https://openalex.org/C2779829264","wikidata":"https://www.wikidata.org/wiki/Q21011228","display_name":"Dulaglutide","level":5,"score":0.970786452293396},{"id":"https://openalex.org/C2909862629","wikidata":"https://www.wikidata.org/wiki/Q27261089","display_name":"Semaglutide","level":5,"score":0.944898247718811},{"id":"https://openalex.org/C2781308992","wikidata":"https://www.wikidata.org/wiki/Q2526479","display_name":"Liraglutide","level":4,"score":0.9374030828475952},{"id":"https://openalex.org/C2780533449","wikidata":"https://www.wikidata.org/wiki/Q417762","display_name":"Exenatide","level":4,"score":0.9211475849151611},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8480274677276611},{"id":"https://openalex.org/C2776442814","wikidata":"https://www.wikidata.org/wiki/Q6659956","display_name":"Lixisenatide","level":5,"score":0.7168053388595581},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.6818002462387085},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5956354141235352},{"id":"https://openalex.org/C185280430","wikidata":"https://www.wikidata.org/wiki/Q14909910","display_name":"Glucagon-like peptide 1 receptor","level":4,"score":0.5229718685150146},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.5212500691413879},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.5198912620544434},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.4636697769165039},{"id":"https://openalex.org/C2780668416","wikidata":"https://www.wikidata.org/wiki/Q202758","display_name":"Hypoglycemia","level":3,"score":0.4488511383533478},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3915536403656006},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.16646915674209595}],"mesh":[{"descriptor_ui":"D000067758","descriptor_name":"Glucagon-Like Peptide-2 Receptor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000069450","descriptor_name":"Liraglutide","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000097789","descriptor_name":"Glucagon-Like Peptide-1 Receptor Agonists","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D000099194","descriptor_name":"Semaglutide","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001786","descriptor_name":"Blood Glucose","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D001835","descriptor_name":"Body Weight","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D004763","descriptor_name":"Glucagon-Like Peptides","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D004763","descriptor_name":"Glucagon-Like Peptides","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D006442","descriptor_name":"Glycated Hemoglobin","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D007141","descriptor_name":"Immunoglobulin Fc Fragments","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D010455","descriptor_name":"Peptides","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D011993","descriptor_name":"Recombinant Fusion Proteins","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1530/eje-19-0566","doi":"https://doi.org/10.1530/eje-19-0566","is_oa":false,"landing_page_url":"https://doi.org/10.1530/eje-19-0566","pdf_url":null,"source":{"id":"https://openalex.org/S4210218062","display_name":"European Journal of Endocrinology","issn_l":"0804-4643","issn":["0804-4643","1479-683X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Journal of Endocrinology","raw_type":"journal-article"},{"id":"pmid:31600725","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/31600725","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European journal of endocrinology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":91,"referenced_works":["https://openalex.org/W135921014","https://openalex.org/W164555988","https://openalex.org/W1482561371","https://openalex.org/W1507814807","https://openalex.org/W1578533615","https://openalex.org/W1596575266","https://openalex.org/W1701595965","https://openalex.org/W1966748421","https://openalex.org/W1968183110","https://openalex.org/W1969932276","https://openalex.org/W1973328187","https://openalex.org/W1974830397","https://openalex.org/W1976503602","https://openalex.org/W1977102586","https://openalex.org/W1977119153","https://openalex.org/W1978191819","https://openalex.org/W1984845045","https://openalex.org/W1986085856","https://openalex.org/W2001097346","https://openalex.org/W2002757015","https://openalex.org/W2003141714","https://openalex.org/W2008411184","https://openalex.org/W2009288620","https://openalex.org/W2013851956","https://openalex.org/W2023462541","https://openalex.org/W2050250967","https://openalex.org/W2054981500","https://openalex.org/W2056494500","https://openalex.org/W2063715420","https://openalex.org/W2067533175","https://openalex.org/W2070710390","https://openalex.org/W2079123198","https://openalex.org/W2095994700","https://openalex.org/W2103274121","https://openalex.org/W2116296155","https://openalex.org/W2117764934","https://openalex.org/W2118929450","https://openalex.org/W2126862523","https://openalex.org/W2127782831","https://openalex.org/W2127854619","https://openalex.org/W2135064706","https://openalex.org/W2136254957","https://openalex.org/W2138077952","https://openalex.org/W2139485303","https://openalex.org/W2140536043","https://openalex.org/W2142830692","https://openalex.org/W2152984355","https://openalex.org/W2156365419","https://openalex.org/W2159205789","https://openalex.org/W2161051960","https://openalex.org/W2162001095","https://openalex.org/W2162140339","https://openalex.org/W2162934281","https://openalex.org/W2163229244","https://openalex.org/W2170606300","https://openalex.org/W2176260350","https://openalex.org/W2201157965","https://openalex.org/W2261184724","https://openalex.org/W2301861796","https://openalex.org/W2335878298","https://openalex.org/W2344263484","https://openalex.org/W2344620176","https://openalex.org/W2410056512","https://openalex.org/W2505843168","https://openalex.org/W2519510391","https://openalex.org/W2542456927","https://openalex.org/W2544950685","https://openalex.org/W2550011910","https://openalex.org/W2599428142","https://openalex.org/W2607581455","https://openalex.org/W2626446274","https://openalex.org/W2746874591","https://openalex.org/W2754041380","https://openalex.org/W2766836053","https://openalex.org/W2770419013","https://openalex.org/W2774157762","https://openalex.org/W2774301756","https://openalex.org/W2785139619","https://openalex.org/W2787255324","https://openalex.org/W2808008353","https://openalex.org/W2894627590","https://openalex.org/W2894746763","https://openalex.org/W2900149048","https://openalex.org/W2903677519","https://openalex.org/W2912404136","https://openalex.org/W2922550132","https://openalex.org/W2948380809","https://openalex.org/W2948519518","https://openalex.org/W2948612418","https://openalex.org/W2948622224","https://openalex.org/W4234825176"],"related_works":["https://openalex.org/W4361829012","https://openalex.org/W2105554519","https://openalex.org/W2786333471","https://openalex.org/W4289779349","https://openalex.org/W2905566236","https://openalex.org/W2553721118","https://openalex.org/W2007217090","https://openalex.org/W2049798496","https://openalex.org/W2004932692","https://openalex.org/W3211003663"],"abstract_inverted_index":{"GLP-1,":[0],"a":[1,17,44,99],"peptide":[2],"hormone":[3],"secreted":[4],"from":[5],"the":[6,107,139,172,197,200,226],"gut,":[7],"stimulating":[8],"insulin":[9],"and":[10,30,80,90,97,138,169,183,192,218,224],"suppressing":[11],"glucagon":[12],"secretion":[13],"was":[14,26,66],"identified":[15],"as":[16,43,106],"parent":[18],"compound":[19],"for":[20,135],"novel":[21],"treatments":[22],"of":[23,74,114,160,199,214,225,228],"diabetes,":[24],"but":[25],"degraded":[27],"(dipeptidyl":[28],"peptidase-4)":[29],"eliminated":[31],"(mainly":[32],"by":[33],"kidneys)":[34],"too":[35],"fast":[36],"(half-life":[37],"1-2":[38],"min)":[39],"to":[40,53,87,174,203],"be":[41],"useful":[42],"therapeutic":[45],"agent.":[46],"GLP-1":[47,119,229],"receptor":[48,120,230],"agonist":[49,231],"has":[50],"been":[51,95,146],"used":[52],"treat":[54],"patients":[55,237],"with":[56,71,81,85,240],"type":[57],"2":[58],"diabetes":[59,110],"since":[60],"2007,":[61],"when":[62],"exenatide":[63,126],"(twice":[64],"daily)":[65],"approved":[67],"in":[68,98,148,156,188,236],"2007.":[69],"Compounds":[70],"longer":[72],"duration":[73],"action":[75],"(once":[76],"daily,":[77],"once":[78],"weekly)":[79],"increasingly":[82],"better":[83],"efficacy":[84],"respect":[86],"glycaemic":[88],"control":[89],"body":[91,216],"weight":[92,217],"reduction":[93],"have":[94,145],"developed,":[96],"recent":[100],"ADA/EASD":[101],"consensus":[102],"statement,":[103],"were":[104],"recommended":[105],"first":[108,140,175],"injectable":[109],"therapy":[111],"after":[112],"failure":[113],"oral":[115,141,143],"glucose-lowering":[116,211],"medications.":[117],"Most":[118],"agonists":[121],"(lixisenatide":[122],"q.d.,":[123,125],"liraglutide":[124],"q.w.,":[127,129,131,133],"dulaglutide":[128,170],"albiglutide":[130],"semaglutide":[132],"all":[134],"s.c.":[136],"injection,":[137],"preparation,":[142],"semaglutide)":[144],"examined":[147],"cardiovascular":[149,178,185,191,221,234,244],"outcomes":[150,235],"studies.":[151],"Beyond":[152],"proving":[153],"their":[154],"safety":[155],"vulnerable":[157],"patients,":[158],"most":[159],"whom":[161],"had":[162],"pre-existing":[163,243],"heart":[164,250],"disease,":[165],"liraglutide,":[166],"semaglutide,":[167],"albiglutide,":[168],"reduced":[171,190],"time":[173],"major":[176],"adverse":[177],"events":[179],"(non-fatal":[180],"myocardial":[181],"infarction":[182],"stroke,":[184],"death).":[186],"Liraglutide,":[187],"addition,":[189],"all-cause":[193],"mortality.":[194],"It":[195],"is":[196],"purpose":[198],"present":[201],"review":[202],"describe":[204],"clinically":[205],"important":[206],"differences,":[207],"regarding":[208],"pharmacokinetic":[209],"behaviour,":[210],"potency,":[212],"effectiveness":[213],"reducing":[215],"controlling":[219],"other":[220],"risk":[222],"factors,":[223],"influence":[227],"treatment":[232],"on":[233],"either":[238],"presenting":[239],"or":[241,248],"without":[242],"disease":[245],"(atherosclerotic,":[246],"ischemic":[247],"congestive":[249],"failure).":[251]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2979558564","counts_by_year":[{"year":2026,"cited_by_count":43},{"year":2025,"cited_by_count":47},{"year":2024,"cited_by_count":36},{"year":2023,"cited_by_count":37},{"year":2022,"cited_by_count":50},{"year":2021,"cited_by_count":55},{"year":2020,"cited_by_count":26}],"updated_date":"2026-11-19T14:11:59.513116","created_date":"2019-10-18T00:00:00"}
